Dosage start with 0.1ml ( 10 insulin units) once a week, up the dose slightly each month according to you and an individual for best results 
Mounjaro is used to help lower blood sugar in adults with type 2 diabetes; it should be used together with diet and exercise.
When tirzepatide (Mounjaro) is used for type 2 diabetes, it can be used as a single therapy (on its own) or with other diabetes medicines, including sulfonylureas, SGLT2 inhibitors, or metformin.
It is not known if tirzepatide can be used in people who have had pancreatitis. Tirzepatide should not be used in people who have type 1 diabetes.
Mounjaro and Zepbound both contain the same active ingredient, tirzepatide.
How does tirzepatide work?
Tirzepatide is a GIP and GLP-1 receptor agonist, so it works (mechanism of action) by activating both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) hormone receptors. GLP-1 helps control appetite and calorie intake, and GIP is thought to contribute to regulating food intake as well.